Loading clinical trials...
Loading clinical trials...
Predictive Value of C-Reactive Protein in Acute Diverticulitis
The management of acute diverticulitis maybe better if we have prognostic markers of evolution. Hypothesis: C-reactive protein maybe a good prognostic marker of evolution of acute diverticulitis. The investigators need to know the values of C-reactive protein to predict evolution of acute diverticulitis.
A prospective observational study. All the patients with TC-diagnosis of acute diverticulitis (AD) had a C-reactive protein (PCR) in the initial blood test. The investigators will predict evolution of AD with the PCR initial.
Age
18 - 90 years
Sex
ALL
Healthy Volunteers
No
Corporacion Parc Tauli
Sabadell, Barcelona, Spain
Corporacion parc tauli
Sabadell, Sabadell-Barcelona, Spain
Corporacion Parc Tauli
Sabadell, Sabadell/barcelona, Spain
Corporacion Parc Tauli
Sabadell, Sabadell/barcelona, Spain
Start Date
April 1, 2013
Primary Completion Date
April 1, 2014
Completion Date
April 1, 2014
Last Updated
April 10, 2013
30
ESTIMATED participants
C-reactive protein
OTHER
Lead Sponsor
Corporacion Parc Tauli
NCT06344078
NCT06388538
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04663490